Advertisement

Topics

Cerberus in advanced talks to buy Teva's oncology assets - report

12:42 EDT 27 Sep 2017 | Globes

Cerberus has teamed with Royalty Pharma to bid about $1 billion for Teva's European oncology and pain treatment portfolio, "Bloomberg" reports.

Original Article: Cerberus in advanced talks to buy Teva's oncology assets - report

NEXT ARTICLE

More From BioPortfolio on "Cerberus in advanced talks to buy Teva's oncology assets - report"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...